New Formulation of Prostate Cancer Drug Could Transform Cancer Treatment
Novel formulation of the cancer drug called abiraterone acetate, which is currently marketed as Zytiga, can dramatically improve the quality of life for people who have prostate cancer.
No comments:
Post a Comment